D
RenovoRx, Inc. RNXT
$1.34 -$0.01-0.74% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -26.17% 13.86% -0.02% 17.85% 20.63%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 103.83% 6.34% 120.42% -35.65% -330.70%
Change in Net Operating Assets -196.90% -53.72% -100.59% -141.79% 293.16%
Cash from Operations -5.60% 11.05% 11.51% 5.57% -3.57%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -100.00% -100.00% --
Cash from Investing -- -100.59% -100.00% -100.00% --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 96.79% 201.88% 201.04% 200.50% 47,272.73%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 96.79% 201.88% 201.04% 200.50% 47,272.73%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,430.48% 285.86% 4,664.66% 81.73% 107.09%